Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice | Charles Explorer

Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice

Publication at First Faculty of Medicine |

2007

Abstract

HPMA, human immunoglobulin, doxorubicin, tumour therapy

People